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Introduction: 1
Benign ovarian cysts are very commonly seen in Gynecological practice with the majority 2 requiring (excluding functional cysts) surgical excision preferably through the laparoscope. 3
However, there has been growing evidence suggesting a decline in ovarian reserve as a result of 4 ovarian cystectomy with possible compromise to fertility potential (1, 2, 3). It remains to be 5 determined whether this damage to the ovarian reserve is related to the procedure itself or to the 6 nature, size and laterality of the cyst. 7
Anti-Müllerian hormone (AMH) is a dimeric glycoprotein, which is a member of the transforming 8 growth factor family. In the female, it is exclusively secreted by granulosa cells of primary, 9 preantral and small antral follicles (4-6 mm) (4). It is now well established that circulating AMH 10 gradually declines with advancing age reflecting the decline in the number of the small antral 11 follicles, rendering it an ideal marker for the early detection of reduced ovarian reserve. 12
Furthermore, serum AMH concentration is generally stable with minimal inter-and intra-cycle 13 fluctuations (5). This makes it an ideal candidate for measuring changes in ovarian reserve 14 following cyst excision. 15
To date, several studies have investigated the impact of ovarian cystectomy on ovarian reserve 16 showing a postoperative decline in circulating AMH (2, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . However, given the relatively small 17 size of these studies, further evidence is required to allow a firm conclusion. We have previously 18
conducted a meta-analysis of studies investigating the effect of excision of endometriomas on 19 ovarian reserve (1). 20
The aim of this meta-analysis was to investigate the impact of excision of benign non-21
comparability factors and used the cutoff level of six stars with a minimum of three stars in the 1 comparability category (1). Table 1 shows the results of quality scores of the studies included in 2 this analysis. 3
Data analysis 4
Pre-and post-operative data including mean ± SD serum concentrations AMH (ng/mL) and FSH 5 (mIU/mL) and AFC were extracted from the individual studies and pooled using RevMan software 6 and I 2 statistics. A Chi 2 statistic larger than its degree of freedom or an I 2 higher than 50% was 10 indicative of significant heterogeneity between studies. When heterogeneity was significant, a 11 random-effect model was used for meta-analysis. Fixed effect meta-analysis was used when 12 there was no significant heterogeneity. 13
The initial analysis included data from all studies, irrespective of length of follow-up and cyst 14 characteristics (diameter, laterality and pathological type). In studies with multiple post-operative 15 measurements at different follow up points, we used the latest AMH level. Further subgroup 16 analyses of AMH levels were then performed based on the laterality of the excised cysts, AMH 17 kits used, and duration of follow-up. To examine and account for heterogeneity, a sensitivity 18 analysis was carried out based on modified Newcastle Ottawa scale for risk of bias as described 19 above. Studies with the lowest risk of bias were defined as those with a score of ≥6 with at least 20 three stars on comparability score and using the same surgical approach (laparoscopy). 21 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT title and abstract to exclude studies which were not relevant to our objectives. As a result, ten 1 articles were viewed in full. 2
Excluded studies 3
After the initial screening on the basis of the title and abstract, ten studies did not use AMH to 4 investigate ovarian reserve after surgery for benign non-endometriotic cyst and were therefore 5 excluded (25-34). Five further studies were excluded, one due to the small number of patients 6 (n=3) (19), another study due to extremely low AMH levels (below the sensitivity of AMH assays) 7 (16) and three studies due to missing the mean±SD of serum AMH concentrations (data were 8 either presented as median{IQR}) (2, 18) or mean±SE% (17). The authors of the latter three 9 studies were contacted to provide the AMH data, but no response was received. 10
Included studies 11
Details of the included ten studies are shown in table 2. 12
Study design 13
The included studies were all cohort studies except one, which was a randomized controlled trial 14 (RCT) (7). However, both arms of the RCT (laparoscopy and laparotomy) were combined and 15 included in the initial meta-analysis as a cohort study. One arm (laparoscopy) was then included 16 in the sensitivity analysis (7). 17
Participants 18
Selection criteria were appropriate for all studies. All participants underwent the same type of 19 surgery (cystectomy) through laparoscopy except one study, where patients were randomly 20 allocated to either laparoscopy or laparotomy (7). Patients of this RCT were consecutive and were 21 followed up within their particular group and the results were given separately for each arm of the
The author of that study was contacted but did not reply. All patients were accounted for in all 1 studies. 2
Ovarian cyst diagnosis 3
Most of the studies reported that the initial diagnosis of the cysts was achieved through 4 transvaginal ultrasound. The ultrasound scans were performed by Gynecologists with sufficient 5 experience. Postoperatively, the nature of the cyst was confirmed with histopathological 6 examination. Six studies reported the mean ± SD cyst diameter (6-9, 12, 15) and six studies 7 determined the side and laterality of the cysts (6-8, 11, 12,15) . 8
Surgery and length of follow up 9
All studies included patients undergoing ovarian cystectomy carried out laparoscopically except 10 one study, which was an RCT comparing laparoscopic versus open cystectomy (7). The length of 11 follow up was one month in four studies (11, 12, 14, 15), three months in six studies (6, 8, 9 , 10, 12 12, 14), six months in one study (7). 13
AMH kits 14
AMH concentration was measured using one of the four available kits. The first one was IOT AMH 15 / MIS enzyme immunoassay (EIA) kit (Immunotech, Beckman Coulter, Marseille, France). The 16 intra-and inter-assay coefficients of variation for the AMH assay were below 12.3% and 14.2%, 17 respectively, with a detection limit of 0.14 ng/mL (9, 11). Second AMH kit was DSL active 18
Müllerian-inhibiting substance / AMH ELISA kit (Diagnostic Systems Laboratories, Webster TX). 19
The intra-and inter-assay coefficients of variation for AMH were 4.6% and 8.0%, respectively, 20 with a detection limit of 0.017 ng/mL (7, 10, 12, 14). The third kit was the AMH Gen II enzyme 21 linked immunosorbent assay (ELISA) (Beckman Coulter, Chaska, MN, USA). The intra and enterassay coefficients of variation for the AMH assay were both below 10%, with a detection limit of 23 0.08 ng/mL (6, 8) . Two studies used this kit including Ergun and co-workers (6) who used theM A N U S C R I P T
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modified AMH Gen II kit and Kwon and co-workers who used the original Gen II assay (8). The 1 fourth kit was the Ultra-Sensitive AMH ELISA Ansh Labs assay (Ansh Labs, UK). The intra and 2
Inter-assay coefficients of variation for the AMH were 0.02 (2.22/95) and 7.81 (15.62/2), 3 respectively, with a detection limit of 0.06 ng/ml (15) . 4
Potential source of bias 5
In all studies, patients were selected in a consecutive fashion (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The selection method was 6 clearly described making it easy to assess selection bias. 7
Overall pooled results for all studies 8
The initial analysis of the ten studies included all 367 patients who underwent cystectomy for 9 unilateral or bilateral benign non-endometriotic ovarian cysts. The analysis revealed a statistically 10 significant postoperative fall in serum AMH concentrations (WMD -1.14 ng/ml; 95% confidence 11 interval (CI) -1.36 to -0.92). Heterogeneity between studies was low (I 2 = 43 %) (6-15) (Fig. 2) . 12
Subgroup analysis 13
Laterality of benign non-endometriotic ovarian cysts 14
Six studies included 206 patients undergoing unilateral ovarian cystectomy (6-8, 11, 12, 15) . 15
Results showed a statistically significant decline in serum AMH level after surgery (WMD -0.97 16 ng/ml; 95% CI -1.58 to -0.37; I 2 = 73%). Bilateral ovarian cystectomy was reported in five studies 17 including 23 patients (6, 8, 11, 12, 15) . Pooled analysis of the data revealed no statistical 18 
Studies using different AMH assays 2
Analysis of four studies (n=197) using DSL AMH kit revealed a statistically significant decline in 3 postoperative AMH level (WMD -1.18; 95% CI -1.85 to -0.52; I 2 =81%) (7, 10, 12, 14) . Pooled 4 analysis of two studies (n=56) using Gen II AMH assay showed a statistically significant fall in 5 postoperative serum AMH level (WMD -0.88; 95% CI -1.71 to -0.04; I 2 =0%) (6, 8) . Two other 6 studies (n=58) using IOT AMH assay revealed a statistically significant decline in postoperative 7 AMH level (WMD -1.56; 95% CI -2.44 to -0.69; I 2 = 22%) (9, 11). Heterogeneity between studies 8 was low for studies using Gen II and IOT AMH kits. One study used the new Ultrasensitive AMH 9
ELISA assay an showed significant decline I circulating AMH (15) . 10
Sensitivity analysis 11
Pooled analysis of eight studies with low risk of bias (as defined above) including 297 patients 12 showed a statistically significant fall in postoperative serum AMH concentration (WMD -1.05; 95% 13 CL -1.29 to -0.81; I 2 = 43%). Heterogeneity between studies was low (6, 7, 8, 9, 11, 12, 14, 15). 14
Studies with ovarian cyst >5 cm: 15
Seven studies including 276 patients were identified (6, 7, 8, 9, 12, 14, 15) . Pooled analysis 16 revealed a statistically significant fall in postoperative serum AMH concentration (WMD -1.13; 17 95% CI -1.56 to -0.70; I 2 =62%). Heterogeneity between studies was high. 18
Studies with different histological types 19
Analysis of six studies including 158 patients with dermoid cysts revealed a statistically significant 20 fall in serum AMH concentration (WMD -1.27; 95% CI -1.93 to -0.62; I 2 = 55%) (6, 7, 9, 11, 12, 14) . 21
Similarly, analysis of four studies including 84 patients with cystadenomas showed a statistically 22 significant decline in serum AMH concentration (WMD -1.59; 95% CI -2.00 to -1.17; I 2 = 0%) (6, 7, 
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11, 14). 1
Secondary outcomes 2
Three studies measured changes in serum FSH concentrations (6, 11, 12), but only two (including 3 95 patients) of them provided full pre-and post-operative data (6, 12) . Pooled analysis of these 4 two studies revealed no significant change in circulating FSH following ovarian cystectomy (WMD 5 -0.50; 95% CI -1.28 to 0.28; I 2 = 0%). Authors of the other study (11) reported that FSH levels did 6 not change after surgery, but failed to present the actual data. 7
With regards to AFC, although one study included this ovarian reserve marker as an outcome 8 measure, the authors provided the postoperative AFC data only and failed to present the 9 preoperative values (7). 10
Comment
11
This is the first meta-analysis to investigate the impact of ovarian cystectomy for benign non-12 endometriotic cysts on ovarian reserve as determined by changes in postoperative serum AMH 13 concentration. The initial analysis revealed a marked decline of 1.14 ng/ml, which represents 14 about 38% of the cut-off level of normal AMH (3.1 ng/ml). This decline in AMH seems to be 15 sustained for up to six months. Further subgroup and sensitivity analysis were performed to 16 minimise the risk of bias and to take into account all possible confounding factors. Heterogeneity 17 was lowest between studies using Gen II and IOT AMH kits, studies with three-month follow-up 18 after surgery and studies including excision of cystadenomas. This further analysis still showed a 19 statistically significant decline in postoperative serum AMH. 20
Interestingly, this magnitude of AMH decline is similar to that observed after excision of ovarian 21 endometriomas as reported in our previous meta-analysis (1). This is surprising as excision of 22 endometriomas is generally perceived to be more destructive to the ovary than excision of non-23 endometriotic cysts. This may therefore suggest that the decline in circulating AMH after ovarianM A N U S C R I P T
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cystectomy is not related to the nature of the cyst excised. 1
The mechanism of the observed fall in circulating AMH following ovarian cystectomy remains 2 largely unknown. Possible explanation could be the concomitant removal of normal ovarian tissue 3 with significant follicular loss (35). Another possible mechanism is the thermal damage to ovarian 4 tissue due to excessive use of diathermy for hemostasis (2, 3). 5
It is interesting to see this marked drop of circulating AMH (about 38%) following unilateral 6 ovarian cystectomy. It is well established that circulating AMH is generally stable throughout the 7 reproductive years with minimal inter-cycle variation and with very small and gradual decline with 8 advancing age until 40. Bentzen and co-workers reported an AMH level decline of 5.6% per year 9 (36). We therefore believe that a 38% decline in AMH level after cystectomy represents a 10 relatively marked drop, which appears to be clinically significant. However, unlike the age related 11 decline, it is unlikely that the observed post cystectomy AMH fall reflects an equivalent decline in 12 ovarian reserve and fertility potential. It is well established that circulating AMH corresponds to the 13 number of small antral follicles, but does not directly correspond to the total follicular pool of the 14 ovary. It is possible that postoperative fall in AMH reflects loss/damage of small antral follicles, 15 which are the only source of AMH, but may have no significant impact on the total number of 16 primordial follicles. In order to investigate this hypothesis, further studies are required to assess 17 the long term changes in circulating AMH as well as the reproductive performance following 18 ovarian cystectomy. Until such evidence becomes available, it may be prudent for clinicians to 19 counsel their patients with regards to the potential damaging effect of cystectomy on ovarian 20 reserve. A more conservative approach (if malignancy can be confidently ruled out) could be 21 considered whenever clinically possible and appropriate such as deferring surgery until 22 completion of family.
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this meta-analysis. The majority of studies (Seven studies, n=253) performed the measurement at 1 three-month follow-up after surgery (6, 7, 8, 9, 10, 13, 14) and one study (7) performed multiple 2 measurements (n=59). In this study, we used the latest samples, which are likely to reflect the 3 most sustained change of circulating AMH after surgery. Analysis of studies with repeated AMH 4 measurements at one and three-month follow-up showed a sustained decline in AMH, indicating 5 that ovarian reserve does not seem to recover within three months. 6
Surgery for bilateral ovarian cysts 7
Although, excision of bilateral ovarian cysts is expected to cause more damage to ovarian 8 reserve, it was surprising to see that analysis of studies with bilateral cystectomy did not reveal a 9 significant drop in AMH. However, the numbers included in this analysis was too small (n=23) to 10 allow any firm conclusion. 11
Cyst diameter (>5 cm) 12
The purpose of this analysis was to adjust for the variation in cyst size as a possible confounding 13 factor. Cyst size did not seem to affect the magnitude of postoperative fall in circulating AMH as 14 indicated by the WMD, which is similar to that of the overall analysis of all included patients 15 regardless of the cyst size. 16
AMH kits 17
It is well recognized that different AMH kits give different results and have different sensitivities 18 and inter-and interassay CV. IOT assay (Immunotech, Beckman Coulter, Marseille, France) has 19 been found to produce AMH concentrations 40% higher compared with DSL AMH assay (DSL, 20
Webster, TX, USA), making it difficult to combine/compare results from different studies (37). In 21 enzymatic, microplate assay (the AMH Gen II assay) was introduced. The Gen II assay is 23 calibrated to the old IOT standards and AMH levels are thus comparable to the IOT assay andM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 40% higher than the previous DSL version (38, 39, 40, 41). 1 Interestingly, studies using AMH Gen II assay showed a significantly smaller postoperative 2 decline in AMH (WMD -0.88 ng/ml) compared with that observed with IOT kit (WMD -1.56 ng/ml), 3 and with DSL assay (WMD -1.18 ng/ml). It is difficult to explain this unexpected difference in the 4 magnitude of AMH decline between Gen II and IOT kits, which have been calibrated to produce 5 comparable results. 6
Conclusion 7
In conclusion, excision of benign non-endometriotic ovarian cyst seems to cause marked decline 8 (38%) in circulating AMH. Whether this reflects a long term damage to ovarian reserve with 9 subsequent decline in fertility potential remains to be determined. Given the high heterogeneity 10 between studies, this meta-analysis should be interpreted with caution. 
